Insiders · Profile

Schadt Eric

President & Chief R&D Officer at GeneDx. Filing since 25 Oct 2021. CIK 0001873468

Company
Date
Role
Action
Shares
Amount
Of holding
20 May 2022
President & Chief R&D Officer
Bought
100,000
$192.48K
69.7%
28 Apr 2022
President & Chief R&D Officer
Sold, plan not stated
35,899
$78.27K
20.0%
28 Jan 2022
Chief Executive Officer
Sold, plan not stated
29,100
$82.67K
22.5%
25 Oct 2021
Chief Executive Officer
Sold, plan not stated
33,332
$251.32K
42.3%
4 decisions on file.